Paladin CEO still shopping for deals; Bayer chief declares 6% Japanese growth goal;

@FiercePharma: Drugmakers aren't the only ones upset about German pricing policies More | Follow @FiercePharma

> Paladin Labs says it is still scouting for acquisitions after its hostile bid for Afexa failed in the face of a higher offer from Valeant Pharmaceuticals. Story

> Bayer CEO Marijn Dekkers told a Tokyo audience that his company plans to grow 6% per year through 2015, to reach 2.4 billion euros in Japanese sales. Report

> The U.K.'s cost-effectiveness watchdog has been asked to review the implications of broader off-label prescribing among National Health Service doctors. Report

> Pozen is scouting for a pharma partner to help market its in-development heart drug. Item

> Omnicare, the pharmacy services firm, extended its hostile bid for PharMerica by two months. More

> Drug wholesaler AmerisourceBergen agreed to buy patient access and reimbursement services firm TheraCom for $250 million. Article

Biotech News

@FierceBiotech: People with Huntington's overexpress a gene call H2AFY. Biomarker could eventually help gauge effectiveness of new drugs. Piece | Follow @FierceBiotech

@ JohnCFierce: "We're going after a new area of biology," says Agios CEO Schenkein. "And we're going after it hard." Article | Follow @JohnCFierce

@RyanMFierce: I hope this approach to combating brain cancer works as well in man as it did in mice. Story | Follow @RyanMFierce

@MaureenFierce: Good news and bad news: So many jobs are gone, pharma layoffs dwindle. Item | Follow @MaureenFierce

> Agios wins $20M haul as Celgene extends cancer development pact. News

> Detailed BG-12 data supports Biogen's blockbuster MS ambitions. Article

> BioCryst shares surge on positive IIb study for gout drug. More

Medical Device News

> Cambridge Heart reports positive results from MTWA-CAD study. Item

> Ventana wins clearance for H. pylori antibody. Report

> Interrad scores $10M in Series C. More

> FDA unveils streamlined de novo guidelines. Report

> With inexpensive materials, iPhone becomes imaging device. Story

> NEA leads $16M round for drug-eluting balloon firm. Piece

Drug Delivery News

> Probe of HIV peptide leads to drug-delivery clues. News

> Mission Pharmacal hitches onto TriLogic's delivery tech. Article

> Ultrasound-guided drug delivery gets FDA nod. Report

> Biotechs grab funds for drugs that cross brain barrier. More

> Search-and-destroy drugs attack lethal brain cancer. Story

And Finally... A new animal study hints that Alzheimer's disease might be transmissible, but much more research is needed to determine whether it can spread among humans under normal, outside-the-laboratory circumstances. News

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.